ClassID:

90491

C07B2200/07 - page 4 - CPC Classification

Classification description:

Indexing scheme relating to specific properties of organic compounds Optical isomers

Recent Application in this class:
#901
20160073631
2016-03-17

PROCESS FOR THE PREPARATION OF DIHYDROPYRROLE DERIVATIVES

#902
20160060282
2016-03-03

Method for producing novel organometallic complex and amine compound

#903
20160060206
2016-03-03

Fatty alcohol esters of hydroxycarboxylic acids

#904
20160060201
2016-03-03

Homochiral metal-organic framework with enantiopure pillar[5]arene active domains

#905
20160052865
2016-02-25

Cyclopropylamine derivatives useful as LSD1 inhibitors

#906
20160039809
2016-02-11

P2X7 modulators and methods of use

#907
20160039744
2016-02-11

Process for preparing lacosamide

#908
20160039730
2016-02-11

Pharmaceutical compositions comprising monoterpenes

#909
20160039723
2016-02-11

Stereodynamic chemosensors

#910
20160024004
2016-01-28

Antiviral agents against HBV infection

#911
20160022619
2016-01-28

Inhibitors of indoleamine 2,3-dioxygenase (IDO)

#912
20160016889
2016-01-21

Process for the synthesis of melphalan and the hydrochloride salt

#913
20160016885
2016-01-21

METHOD OF PRODUCING OPTICALLY ACTIVE TRANS-1,2-DIAMINOCYCLOHEXANE

#914
20160009635
2016-01-14

Process for preparing substituted phenylalkanes

#915
20160008803
2016-01-14

Water-insoluble ruthenium catalyst composition for use in aqueous hydrogenation reactions

#916
20160007598
2016-01-14

3′-substituted-abscisic acid derivatives

#917
20160002183
2016-01-07

Synthesis of Tetracyclines and intermediates thereto

#918
20150376102
2015-12-31

Method of producing optically-active aldehyde

#919
20150375219
2015-12-31

Catalyst and method for producing optically active anti-1,2-nitroalkanol compound

#920
20150368173
2015-12-24

Pharmaceutical compositions comprising monoterpenes

#921
20150361025
2015-12-17

Enantioselective process for the preparation of enantiomers of sex pheromones

#922
20150359754
2015-12-17

Methods and devices for using isoperillyl alcohol

#923
20150353477
2015-12-10

Pesticidal compositions and processes related thereto

#924
20150337286
2015-11-26

Cathepsin L inhibitors and probes comprising vinyl sulfonate moiety and methods of using same

#925
20150336943
2015-11-26

NOVEL BENZODIOXANE-PIPERIDINE DERIVATIVES AND THEIR THERAPEUTIC APPLICATIONS FOR TREATING NEUROPSYCHIATRIC DISORDERS

#926
20150336911
2015-11-26

Desferrithiocin polyether analogues

#927
20150329570
2015-11-19

Synthetic route to pactamycin and pactamycin analogs

#928
20150329504
2015-11-19

Beta-alanine derivatives, pharmaceutically acceptable salts thereof, and pharmaceutical composition comprising same as active ingredient

#929
20150329457
2015-11-19

(6R,10R)-6,10,14-trimetylpentadecan-2-one prepared from 6,10-dimetylundec-5-en-2-one or 6,10-dimetylundeca-5,9-dien-2-one

#930
20150329456
2015-11-19

(6R,10R)-6,10,14-trimetylpentadecan-2-one prepared from 6,10,14 trimetylpentadeca-5,9,13-trien-2-one or 6,10,14-trimetylpentadeca-5,9-dien-2-one

#931
20150329452
2015-11-19

METHOD FOR PRODUCING OPTICALLY ACTIVE ISOPULEGOL AND OPTICALLY ACTIVE MENTHOL

#932
20150322068
2015-11-12

Substituted xanthine derivatives

#933
20150322062
2015-11-12

P2X7 modulators

#934
20150321986
2015-11-12

Using mixtures of E/Z isomers to obtain quantitatively specific products by combined asymmetric hydrogenations

#935
20150321971
2015-11-12

Efficient process of asymmetric hydrogenation of unsaturated ketones using additives

#936
20150315128
2015-11-05

Bicyclic compounds

#937
20150299123
2015-10-22

S1P and/or ATX modulating agents

#938
20150299102
2015-10-22

DERIVATIVES OF (-)-VENLAFAXINE AND METHODS OF PREPARING AND USING THE SAME

#939
20150299101
2015-10-22

Solid state forms of tapentadol salts

#940
20150284401
2015-10-08

Chiral fluorinating reagents

#941
20150274650
2015-10-01

Process for the preparation of intermediates useful for the manufacture NEP inhibitors

#942
20150266805
2015-09-24

Method for producing racemate of compound

#943
20150259276
2015-09-17

Method of producing chiral N-substituted allylic amine compounds

#944
20150246063
2015-09-03

ATX modulating agents

#945
20150239861
2015-08-27

Condensation product of theanine derivative and carboxylic acid coumarin derivative, its intermediate, preparation method and use thereof

#946
20150232407
2015-08-20

DRUG SUBSTANCE PREPARATIONS, PHARMACEUTICAL COMPOSITIONS AND DOSAGE FORMS COMPRISING S-(+)-FLURBIPROFEN

#947
20150225333
2015-08-13

Crystalline solid and amorphous forms of (−)-halofenate and methods related thereto

#948
20150218123
2015-08-06

Preparation method for optically active bicyclic gamma-amino acid compound

#949
20150210647
2015-07-30

ATX modulating agents

#950
20150210632
2015-07-30

Process for preparing intermediates useful in the manufacture of NEP inhibitors

#951
20150203493
2015-07-23

Compounds that are S1P modulating agents and/or ATX modulating agents

#952
20150203468
2015-07-23

Histone deacetylase inhibitors and compositions and methods of use thereof

#953
20150197472
2015-07-16

Methods of synthesizing alpha acids and substantially enantiomerically pure compositions thereof

#954
20150196535
2015-07-16

Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereof

#955
20150183716
2015-07-02

Synthesis of chiral amphetamine derivatives by stereospecific, regioselective cuprate addition reaction with aziridine phosphoramidate compounds

#956
20150183715
2015-07-02

Alpha- and gamma-truxillic acid derivatives and pharmaceutical compositions thereof

#957
20150166586
2015-06-18

Chiral phosphines for palladium-catalyzed asymmetric α-arylation of ester enolates to produce tertiary stereocenters in high enantioselectivity

#958
20150152042
2015-06-04

Substituted phenethylamines with serotoninergic and/or norepinephrinergic activity

#959
20150151289
2015-06-04

Iron catalysts with unsymmetrical PNN'P ligands

#960
20150148559
2015-05-28

Process for making amino acid compounds

#961
20150148543
2015-05-28

Methods and compositions for the synthesis of multimerizing agents

#962
20150148360
2015-05-28

3,5,N-trihydroxy-alkanamide and derivatives: method for making same and use thereof

#963
20150133556
2015-05-14

(1S,2S,3S,4R)-3-[(1S)-1-acetylamino-2-ethyl-butyl]-4-uanidino-2-hydroxyl-cyclopentyl-1-carboxylic acid hydrates pharmaceutical uses thereof

#964
20150126743
2015-05-07

Process For The Preparation Of Pyrido [2,1-A] Isoquinoline Derivatives Comprising Optical Resolution Of An Enamine

#965
20150126574
2015-05-07

Atrasentan mandelate salts

#966
20150119396
2015-04-30

(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors

#967
20150105567
2015-04-16

Optically active axially chiral alpha-allenic alcohol, synthesis method and use thereof

#968
20150099636
2015-04-09

Chiral diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex

#969
20150087680
2015-03-26

Glucagon antagonists

#970
20150080382
2015-03-19

Diamine derivatives as inhibitors of leukotriene A4 hydrolase

#971
20150073170
2015-03-12

Kinetic resolution

#972
20150073146
2015-03-12

Preparation of ticagrelor

#973
20150072029
2015-03-12

Materials and methods for reduction of protein tau and treatment of neurodegenerative diseases

#974
20150065469
2015-03-05

Salicylic acid derivatives useful as glucocerebrosidase activators

#975
20150057451
2015-02-26

Simple organic molecules as catalysts for practical and efficient enantioselective synthesis of amines and alcohols

#976
20150057450
2015-02-26

Ruthenium-based complex catalysts

#977
20150051416
2015-02-19

Rhodium catalyst and method for producing amine compound

#978
20150051294
2015-02-19

Myricanol derivatives and uses thereof for treatment of neurodegenerative diseases

#979
20150045575
2015-02-12

Process for preparing fluoroleucine alkyl esters

#980
20150045441
2015-02-12

Crystalline diacylhydrazine and the use thereof

#981
20150045274
2015-02-12

Compounds for a controlled release of active perfuming molecules

#982
20150038731
2015-02-05

Process for preparing carboxylic acids

#983
20150031920
2015-01-29

Process for producing optically active secondary alcohol

#984
20150025235
2015-01-22

Benzamide compounds and related methods of use

#985
20150005539
2015-01-01

Process for the removal of contaminant from a hydrochlorofluoroolefin by extractive distillation

#986
20150005527
2015-01-01

Process for the asymmetric oxidation of organic compounds with peroxides in the presence of a chiral acid catalyst

#987
20140378705
2014-12-25

Separating agent and manufacturing method thereof

#988
20140378459
2014-12-25

Guanidinobenzoic acid compound

#989
20140371449
2014-12-18

Synthesis of triazolopyrimidine compounds

#990
20140371287
2014-12-18

Methods of using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione

#991
20140364649
2014-12-11

Method for producing high-purity ceramide

#992
20140364603
2014-12-11

Neprilysin inhibitors

#993
20140364339
2014-12-11

Versatile and stereospecific synthesis of γ,δ-unsaturated amino acids by Wittig reaction

#994
20140350302
2014-11-27

()-6-(dimethylamino)-4,4-diphenylheptan-3-one

#995
20140350284
2014-11-27

Stereoselective synthesis of metyrosine

#996
20140350283
2014-11-27

Compounds and methods for preparing substituted 3-(1-amino-2-methylpentane-3-yl)phenyl compounds

#997
20140350253
2014-11-27

Asymmetric electrophilic fluorination using an anionic chiral phase-transfer catalyst

#998
20140343285
2014-11-20

Process for the preparation of triazole antifungal drug, its intermediates and polymorphs thereof

#999
20140336412
2014-11-13

Process for the preparation of gamma amino acids and intermediates used in said process

#1000
20140336235
2014-11-13

Substituted biaryl alkyl amides

#1001
20140323744
2014-10-30

Process for preparation of (3)-2,4-di-leaving group-3-methylbut-1-ene

#1002
20140323387
2014-10-30

5,5-dimethyl-2-propyl-hexahydro-2,4a-methano-naphthalen-1-one as a fragrance agent

#1003
20140308719
2014-10-16

Process for producing (R)-3-hydroxybutyl (R)-3-hydroxybutyrate

#1004
20140303196
2014-10-09

Salts of the janus kinase inhibitor (R)-3(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile

#1005
20140296584
2014-10-02

Method for producing optically active alcohols

#1006
20140296241
2014-10-02

Use of (2R, 6R)-hydroxynorketamine, (S)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (R,S)-ketamine in the treatment of depression and neuropathic pain

#1007
20140288176
2014-09-25

Enantiomers of 2-hydroxy derivatives of fatty acids

#1008
20140271488
2014-09-18

Chiral oligomeric pentenoate amides as bio-oligomer mimetics

#1009
20140256982
2014-09-11

Production of adipic acid and derivatives from carbohydrate-containing materials

#1010
20140256976
2014-09-11

Process for the preparation of aminoacrylic acid derivatives

#1011
20140249194
2014-09-04

Optically active fluconazole analogues containing thiophenes as antifungal agents

#1012
20140243526
2014-08-28

Selective hydrogenation of aldehyde with ru/bidentate ligands complexes

#1013
20140235591
2014-08-21

Tetrahydronaphthalenyl compounds useful as sipi agonists

#1014
20140234939
2014-08-21

Benzamide compounds and related methods of use

#1015
20140228592
2014-08-14

Arylated β-dicarbonyl compounds and process for the preparation thereof

#1016
20140221662
2014-08-07

Intermediate compounds of tamiflu, methods of preparation and uses thereof

#1017
20140212916
2014-07-31

Method for diagnosing infection

#1018
20140212486
2014-07-31

Isometheptene isomer

#1019
20140206905
2014-07-24

Process for preparing chiral quinone

#1020
20140194646
2014-07-10

Alkyl lactyllactates and processes of making the same

#1021
20140194638
2014-07-10

Spirobenzylamine-phosphine, preparation method therefor and use thereof

#1022
20140194509
2014-07-10

Hydroxybutyrate ester and medical use thereof

#1023
20140187809
2014-07-03

Ruthenium complex and method for preparing optically active alcohol compounds using the same as a catalyst

#1024
20140179947
2014-06-26

Process for manufacture and resolution of 2-acylamino-3-diphenylpropanoic acid

#1025
20140171692
2014-06-19

Process for asymetric methylallylation in the presence of a 2,2′-substituted 1,1′-BI-2-naphthol catalyst

#1026
20140171649
2014-06-19

Methods and compositions for the synthesis of multimerizing agents

#1027
20140163225
2014-06-12

Catalysts and processes for the hydrogenation of amides

#1028
20140155637
2014-06-05

Chiral synthesis of N-{3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]-6-methoxyphenyl}-1-[2,3-dihydroxy-propyl]cyclopropanesulfonamides

#1029
20140142336
2014-05-22

Synthetic method of enantiomerically pure 2,2′-dihydroxy-1,1′-binaphthyl-3-carboxylic acid

#1030
20140135520
2014-05-15

Method for manufacturing optically active carboxylic acid ester

#1031
20140128637
2014-05-08

Atropisomeric 1,8-bisphenolnapthalenes and their use in enantioselective recognition and asymmetric synthesis

#1032
20140128581
2014-05-08

Disubstituted amino acids and methods of preparation and use thereof

#1033
20140128474
2014-05-08

Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine

#1034
20140128466
2014-05-08

Compounds for use in the treatment of inflammatory bowel disease

#1035
20140121283
2014-05-01

Methods of using derivatives of (−)-venlafaxine

#1036
20140121282
2014-05-01

Phenyl substituted cycloalkylamines as monoamine reuptake inhibitors

#1037
20140107194
2014-04-17

Compounds for use in the treatment of immune related inflammatory disease

#1038
20140100259
2014-04-10

Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereof

#1039
20140099681
2014-04-10

Process for producing optically active succinimide derivatives and intermediates thereof

#1040
20140093558
2014-04-03

Stable crystal modifications of DOTAP chloride

#1041
20140088048
2014-03-27

Diazeniumdiolate cyclohexyl derivatives

#1042
20140081048
2014-03-20

Method for the preparation of cinacalcet and intermediates and impurities thereof

#1043
20140080916
2014-03-20

Isolated compounds from turmeric oil and methods of use

#1044
20140073809
2014-03-13

Preparation method for rivastigmine, intermediates thereof, and preparation method for said intermediates

#1045
20140066501
2014-03-06

Anhydrous and hemihydrate crystalline forms of an ()-baclofen prodrug, methods of synthesis and methods of use

#1046
20140046095
2014-02-13

Method of preparing (S)-2-amino-5-methoxytetralin hydrochloride

#1047
20140037559
2014-02-06

Process for producing (3S)-1-menthyl 3-hydroxybutyrate and sensate composition

#1048
20140031589
2014-01-30

Process for the preparation of and crystalline forms of optical enantiomers of modafinil

#1049
20140024852
2014-01-23

Crystalline solid and amorphous forms of (−)-halofenate and methods related thereto

#1050
20140018578
2014-01-16

Method for the synthesis of rasagiline

#1051
20140018577
2014-01-16

Process for preparing lacosamide

#1052
20140018548
2014-01-16

Catalyst for asymmetric hydrogenation of imine, synthesis method and application thereof

#1053
20140012016
2014-01-09

Diamino acid derivative starting material, manufacturing method thereof, and diamino acid derivative manufacturing method

#1054
20130345444
2013-12-26

Production method of optically active dihydrobenzofuran derivative

#1055
20130345421
2013-12-26

Process of isolating enantiomer components from enantiomer mixtures by particle-size-controlled crystallization

#1056
20130338399
2013-12-19

Process for preparing substituted 3-(1-amino-2-methylpentane-3-yl)phenyl compounds

#1057
20130331604
2013-12-12

(1S,2S,3S,4R)-3-[(1S)-1-acetylamino-2-ethyl-butyl]-4-guanidino-2-hydroxy-cyclopentyl-l-carboxylic acid hydrates pharmaceutical uses thereof

#1058
20130331454
2013-12-12

PKC-ε activator

#1059
20130331392
2013-12-12

Cycloalkyl guanidine FF-ATPase inhibitors and therapeutic uses thereof

#1060
20130324752
2013-12-05

Crystallization of (20R,22R)-2-methylene-19-nor-22-methyl-1α,25-dihydroxyvitamin Dand related precursors

#1061
20130310555
2013-11-21

Synthesis of therapeutic and diagnostic drugs centered on regioselective and stereoselective ring opening of aziridinium ions

#1062
20130310423
2013-11-21

Diterpenoid derivatives endowed of biological properties

#1063
20130303807
2013-11-14

Pharmaceutical compositions comprising monoterpenes

#1064
20130296599
2013-11-07

Phenylglyoxylic acid derivatives and their preparation and use

#1065
20130296537
2013-11-07

Methamphetamine-like hapten compounds, linkers, carriers and compositions and uses thereof

#1066
20130289118
2013-10-31

Derivatives of aminoalkanols, method of obtaining of aminoalkanols and their use

#1067
20130274344
2013-10-17

Estrogenic compounds, process for their production and pharmaceutical uses thereof

#1068
20130261316
2013-10-03

Neprilysin inhibitors

#1069
20130261298
2013-10-03

Process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid

#1070
20130253228
2013-09-26

Method for manufacturing optically active menthol

#1071
20130245257
2013-09-19

Compound having hetero ring skeleton, and process for producing optically active compound using the aforementioned compound as asymmetric catalyst

#1072
20130244944
2013-09-19

Synthetic ion channels

#1073
20130236515
2013-09-12

Levalbuterol salt

#1074
20130225822
2013-08-29

Chiral spiro-pyridylamidophosphine ligand compound, synthesis method therefor and application thereof

#1075
20130217919
2013-08-22

Asymmetric synthetic processes for the preparation of aminosulfone compounds

#1076
20130217900
2013-08-22

Chiral intermediates useful for the preparation of hydroxyphosphine ligands

#1077
20130217895
2013-08-22

Catalyst for asymmetric hydrogenation and method for manufacturing optically active carbonyl compound using the same

#1078
20130217674
2013-08-22

SHIP1 modulators and related methods

#1079
20130211139
2013-08-15

Process for producing optically active β-amino aldehyde compound

#1080
20130211130
2013-08-15

Process for preparing carboxamidine compounds

#1081
20130211055
2013-08-15

Dithioamine reducing agents

#1082
20130210091
2013-08-15

Process for the enzymatic synthesis of (7S)-3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-triene-7-carboxylic acid or esters thereof, and application in the synthesis of ivabradine and salts thereof

#1083
20130197260
2013-08-01

Processes for the preparation of fesoterodine

#1084
20130197240
2013-08-01

Process for preparing aminoadamantyl carbamate derivatives

#1085
20130197013
2013-08-01

Cyclopropylamine derivatives useful as LSD1 inhibitors

#1086
20130190540
2013-07-25

Method for preparing optically active 1-bromo-1[3,5-bis(trifluoromethyl)phenyl]ethane

#1087
20130190533
2013-07-25

Process for the preparation of amino acid derivatives

#1088
20130184479
2013-07-18

Biaryl diphosphine ligands, intermediates of the same and their use in asymmetric catalysis

#1089
20130184279
2013-07-18

N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases

#1090
20130178651
2013-07-11

Preparation method of high-optical purity N2-[1 -(S)-ethoxycarbonyl-3-phenylpropyl]-N6-trifluoroacetyl-L-lysine

#1091
20130178646
2013-07-11

Fatty alcohol esters of hydroxycarboxylic acids

#1092
20130172597
2013-07-04

Method for producing optically active 1,2-bis(dialkylphosphino)benzene derivative

#1093
20130172543
2013-07-04

Method for oxidizing alcohols

#1094
20130158275
2013-06-20

Process for the preparation of intermediates useful for the manufacture NEP inhibitors

#1095
20130131337
2013-05-23

Optically active ammonium salt compound, production intermediate thereof, and production method thereof

#1096
20130123490
2013-05-16

Process for the asymmetric transfer hydrogenation of ketones

#1097
20130102794
2013-04-25

Process for the preparation of nitrogen substituted aminotetralins derivatives

#1098
20130096348
2013-04-18

Chiral diene ligands, a fabrication method thereof and applications thereof

#1099
20130096339
2013-04-18

Method for producing 1-amino-1-alkoxycarbonyl-2-vinylcyclopropane

#1100
20130090314
2013-04-11

Solid state forms of tapentadol salts

#1101
20130089904
2013-04-11

1-hydroxy-octahydroazulenes as fragrances

#1102
20130089898
2013-04-11

Biocatalysts and methods for the synthesis of ()-3-(1-aminoethyl)-phenol

#1103
20130089612
2013-04-11

R(+)-N-formyl-propargyl-aminoindan

#1104
20130089468
2013-04-11

Separation/detection column and kit thereof

#1105
20130079567
2013-03-28

Enantiopure base-metal catalysts for asymmetric catalysis and bis(imino)pyridine iron alkyl complexes for catalysis

#1106
20130079514
2013-03-28

Omega-aminoalkylamides of R-2-aryl-propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells

#1107
20130079413
2013-03-28

Crystalline diacylhydrazine and the use thereof

#1108
20130079406
2013-03-28

THERAPEUTIC COMPOSITIONS

#1109
20130079400
2013-03-28

Process for the preparation of pleuromutilins

#1110
20130071899
2013-03-21

Process for producing Aliskiren

#1111
20130066111
2013-03-14

Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidation

#1112
20130060065
2013-03-07

Process for the dehydration of substituted 4-dimethylamino-2-aryl-butan-2-ol compounds and process for the preparation of substituted dimethyl-(3-aryl-butyl)-amine compounds by heterogeneous catalysis

#1113
20130060063
2013-03-07

METHOD FOR PRODUCING PRECURSORS FOR L-3,4-DIHYDROXY-6-[18F]FLUOROPHENYLALANINE AND 2-[18F]FLUORO-L-TYROSINE AND THE A-METHYLATED DERIVATIVES THEREOF, PRECURSOR, AND METHOD FOR PRODUCING L-3,4DIHYDROXY-6-[18F]FLUOROPHENYLALANINE AND 2-[18F]FLUORO-L-TYROSINE AND THE A-METHYLATED DERIVATIVES FROM THE PRECURSOR

#1114
20130059919
2013-03-07

Therapeutic compounds

#1115
20130053574
2013-02-28

Asymmetric hydrogenation method for ketone compound

#1116
20130046118
2013-02-21

Method for producing optically active, racemic menthol

#1117
20130046090
2013-02-21

Cyclisation process of forming a multiple ring compound

#1118
20130041026
2013-02-14

Anhydrous and hemihydrate crystalline forms of an ()-baclofen prodrug, methods of synthesis and methods of use

#1119
20130035510
2013-02-07

3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists

#1120
20130035225
2013-02-07

ORGANIC/INORGANIC HYBRID CATALYTIC MATERIALS, THEIR PREPARATION, USE IN SELECTIVE PROCESSES AND REACTORS CONTAINING THEM

#1121
20130030216
2013-01-31

Process for the preparation of lacosamide

#1122
20130030029
2013-01-31

Glucagon antagonists

#1123
20130030028
2013-01-31

Desferrithiocin polyether analogues

#1124
20130028845
2013-01-31

LEVALBUTEROL SALT

#1125
20130018212
2013-01-17

Trivinylcyclohexane stereoisomeric compositions and methods for preparing same

#1126
20130018128
2013-01-17

Process for the preparation of DOPO-derived compounds and compositions thereof

#1127
20130012480
2013-01-10

Crystalline salts of (4S,4AS,5AR,12AS)-4-dimethylamino-3,10,12,12A-tetrahydroxy-7-[methoxy(methyl)amino)-methyl] acid amide and methods of using the same

#1128
20130006020
2013-01-03

Alcohol production method by reducing ester or lactone with hydrogen

#1129
20130005976
2013-01-03

Processes and intermediates for preparing a macrocyclic protease inhibitor of HCV

#1130
20120330030
2012-12-27

Enantioselective Synthesis of y-amino-a, B-unsuturated carboxylic acid derivatives

#1131
20120323040
2012-12-20

Process for synthesis of amino-methyl tetralin derivatives

#1132
20120322053
2012-12-20

Cross-coupled peptide nucleic acids for detection of nucleic acids of pathogens

#1133
20120321773
2012-12-20

Process for producing (3S)-I-menthyl 3-hydroxybutyrate and sensate composition

#1134
20120316361
2012-12-13

Method of resolution of (RS)- 1,1′-BI-2-naphthol for obtaining enantiomeric pure I.E. (S)-(−)-1,1′-BI-2-naphthol and/or (R)-(+)-1,1′-BI-2-naphthol via co-crystal formation with optically active derivatives of γ-amino acids

#1135
20120316350
2012-12-13

Process for the preparation of enantiomerically pure 1-substituted-3-aminoalcohols

#1136
20120316066
2012-12-13

Process of preparing chiral diacylhydrazine ligands

#1137
20120302790
2012-11-29

Process for the preparation of nitrogen substituted aminotetralins derivatives

#1138
20120302643
2012-11-29

Crystalline Forms of (-)-(1R,2R)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenol Hydrochloride

#1139
20120296110
2012-11-22

Process for preparation of pure alkyl esters from alkali metal salt of carboxylic acid

#1140
20120296109
2012-11-22

Levodopa Prodrugs, and Compositions and Uses Thereof

#1141
20120289744
2012-11-15

PROCESS FOR PREPARING OPTICALLY PURE MILNACIPRAN AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS

#1142
20120289510
2012-11-15

Benzyl amines, a process for their production and their use as anti-inflammatory agents

#1143
20120288444
2012-11-15

Single diastereomers of 4-fluoroglutamine and methods of their preparation and use

#1144
20120285816
2012-11-15

METHOD FOR ISOLATING AN ALKANOL FROM AN AQUEOUS BIOTRANSFORMATION MIXTURE

#1145
20120283469
2012-11-08

INTERCONVERSION BETWEEN ISOMERIC P-MENTHANE-3-CARBOXYLIC ACIDS

#1146
20120283463
2012-11-08

Intermediate compounds and processes for the preparation of tapentadol and related compounds

#1147
20120277437
2012-11-01

Kinetic resolution

#1148
20120277240
2012-11-01

Substituted aminotetrahydrothiopyrans and derivatives thereof as dipeptidyl peptidase-IV inhibitors for the treatment of diabetes

#1149
20120270934
2012-10-25

PROSTACYCLIN DERIVATIVES

#1150
20120245379
2012-09-27

Process for the preparation of enantiomerically pure -leucine

#1151
20120238746
2012-09-20

Processes and intermediates for preparing a macrocyclic protease inhibitor of HCV

#1152
20120238549
2012-09-20

Nuclear Hormone Receptor Modulators

#1153
20120232306
2012-09-13

Process for the preparation of tapentadol and intermediates thereof

#1154
20120232303
2012-09-13

Crystalline solid and amorphous forms of (−)-halofenate and methods related thereto

#1155
20120232302
2012-09-13

Process for the Preparation of (-)-(4-Chloro-Phenyl)-(3-Trifluoromethyl-Phenoxy)-Acetic Acid 2-Acetylamino-Ethyl Ester

#1156
20120232157
2012-09-13

Methods of using derivatives of (−)-venlafaxine

#1157
20120214988
2012-08-23

Phosphoramide compound, method for producing the same, ligand, complex, catalyst and method for producing optically active alcohol

#1158
20120214785
2012-08-23

Compounds, pharmaceutical compositions and uses thereof

#1159
20120214775
2012-08-23

Pharmaceutical Salts of 3-O-(3',3'-Dimethylsuccinyl) Betulinic Acid

#1160
20120213806
2012-08-23

Neprilysin inhibitors

#1161
20120197041
2012-08-02

TREPROSTINIL PRODUCTION

#1162
20120196939
2012-08-02

Therapeutic compounds

#1163
20120190898
2012-07-26

Estrogenic compounds, process for their production and pharmaceutical uses thereof

#1164
20120190888
2012-07-26

Treprostinil production

#1165
20120190875
2012-07-26

Compositions and methods for stereoselective aldehyde allylation and crotylation

#1166
20120190743
2012-07-26

COMPOUNDS FOR TREATING DISORDERS OR DISEASES ASSOCIATED WITH NEUROKININ 2 RECEPTOR ACTIVITY

#1167
20120184762
2012-07-19

Process for preparation of phenyl carbamate derivatives

#1168
20120178963
2012-07-12

Metal-catalysed carbonylation of unsaturated compounds

#1169
20120178959
2012-07-12

Process for preparing octenoic acid derivatives

#1170
20120178798
2012-07-12

Substituted cyclopentanes having prostaglandin activity

#1171
20120178705
2012-07-12

Methods for preparation of glycosphingolipids and uses thereof

#1172
20120178666
2012-07-12

PRODRUGS OF GUANFACINE

#1173
20120172339
2012-07-05

ANGIOGENIC RESORCINOL DERIVATIVES

#1174
20120165533
2012-06-28

Optically active diazabicyclooctane derivatives and process for preparing the same

#1175
20120157484
2012-06-21

Tryptophan hydroxylase inhibitors

#1176
20120142949
2012-06-07

PROCESS FOR PREPARING PREGABALIN

#1177
20120142934
2012-06-07

Method for synthesis of secondary alcohols

#1178
20120142668
2012-06-07

CATHEPSIN C INHIBITORS

#1179
20120136176
2012-05-31

Catalyst for asymmetric hydrogenation and method for manufacturing optically active carbonyl compound using the same

#1180
20120136167
2012-05-31

Processes for the preparation of optically active intermediates

#1181
20120136164
2012-05-31

NANOSTRUCTURED METALS

#1182
20120136065
2012-05-31

Treatment of CNS disorders with 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine

#1183
20120136052
2012-05-31

Substituted acylanilides and methods of use thereof

#1184
20120135441
2012-05-31

ENZYMES AND METHODS FOR RESOLVING AMINO VINYL CYCLOPROPANE CARBOXYLIC ACID DERIVATIVES

#1185
20120130097
2012-05-24

PROCESS FOR THE PREPARATION OF CYCLOPROPYL CARBOXYLIC ACID ESTERS AND DERIVATIVES

#1186
20120129945
2012-05-24

Inhibitors of cognitive decline

#1187
20120129927
2012-05-24

New Anthraquinone Derivatives

#1188
20120128773
2012-05-24

Desfesoterodine in the form of a tartaric acid salt

#1189
20120128588
2012-05-24

Isotope labeled 2-arylpropionic acid compounds and process for production of same, and molecular probe for positron emission tomography and method for imaging of cyclooxygenase and the like using same

#1190
20120123161
2012-05-17

Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidation

#1191
20120122940
2012-05-17

Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas

#1192
20120122934
2012-05-17

4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases

#1193
20120122792
2012-05-17

S-t-butyl protected cysteine di-peptide analogs and related compounds

#1194
20120116113
2012-05-10

PROCESS FOR MAKING NEO-ENRICHED p-MENTHANE COMPOUNDS

#1195
20120116112
2012-05-10

Process for the preparation of functionalised benzocyclobutenes, and application in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid

#1196
20120116090
2012-05-10

Chiral Diacylhydrazine Ligands for Modulating the Expression of Exogenous Genes via an Ecdysone Receptor Complex

#1197
20120115818
2012-05-10

Synthesis of tetracyclines and intermediates thereto

#1198
20120114566
2012-05-10

Lipoxin analogs and methods for the treatment of periodontal disease

#1199
20120108846
2012-05-03

Optically active quaternary ammonium salt having axial asymmetry, and method for producing alpha-amino acid and derivative thereof by using the same

#1200
20120108598
2012-05-03

Sitagliptin synthesis